Compare Abbott Laboratories (ABT) vs Vital Farms Inc (VITL) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Vital Farms Inc — how do they compare? Abbott Laboratories trades at $95.59 (market cap $166.94B), while Vital Farms Inc trades at $12.44 (market cap $563.24M). The key difference: Abbott Laboratories is far larger — about 296.4× Vital Farms Inc's market cap, and Abbott Laboratories pays a 2.63% dividend while Vital Farms Inc pays none. Which is the better fit depends on your goals.
| ABT | VITL | |
|---|---|---|
Market Cap | $166.94B | $563.24M |
Sector | Health | Consumer Staples |
52-Week High | $136.62 | $52.41 |
52-Week Low | $82.57 | $8.28 |
Enterprise Value | $193.69B | $566.05M |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
Vital Farms (VITL) trades at $12.84, up 0.63% today, with a bullish technical signal from moving averages but overbought RSI readings. The company reported 2025 revenue of $759.44M and net income of $66.28M, though earnings have missed expectations in recent quarters. Analysts maintain a Buy consensus with a $14.00 price target, but negative cash flow and a class action lawsuit pose headwinds.
The stock offers value with a P/E of 12.35 and P/S of 0.75, but risks include declining profitability, legal challenges, and sustained negative cash flow. Upside depends on execution improvements and resolving litigation, while failure to stabilize earnings could pressure valuations further.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Vital Farms Inc
Vital Farms is a leading provider of ethically produced, pasture-raised eggs and butter in the United States. Operating as a Public Benefit Corporation, it manages a network of over 650 family farms to deliver high-welfare food products. It leverages a scalable 'asset-light' partnership model that prioritizes transparency and animal welfare to meet the growing consumer demand for clean-label and sustainable food sources.
Read more on VITL →
